These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 12957217
1. Anxiety does not affect the antinociceptive effect of Delta 9-THC in mice: participation of cannabinoid and opioid receptors. Takahashi RN, Ramos GA, Assini FL. Pharmacol Biochem Behav; 2003 Jul; 75(4):763-8. PubMed ID: 12957217 [Abstract] [Full Text] [Related]
2. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems. Solinas M, Goldberg SR. Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567 [Abstract] [Full Text] [Related]
3. Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats. Manzanares J, Corchero J, Fuentes JA. Brain Res; 1999 Aug 21; 839(1):173-9. PubMed ID: 10482810 [Abstract] [Full Text] [Related]
4. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids. Janoyan JJ, Crim JL, Darmani NA. Pharmacol Biochem Behav; 2002 Aug 21; 71(1-2):155-62. PubMed ID: 11812518 [Abstract] [Full Text] [Related]
9. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat. Cox ML, Welch SP. Eur J Pharmacol; 2004 Jun 16; 493(1-3):65-74. PubMed ID: 15189765 [Abstract] [Full Text] [Related]
10. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat. Craft RM, Wakley AA, Tsutsui KT, Laggart JD. J Pharmacol Exp Ther; 2012 Mar 16; 340(3):787-800. PubMed ID: 22182934 [Abstract] [Full Text] [Related]
11. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice. Lichtman AH, Sheikh SM, Loh HH, Martin BR. J Pharmacol Exp Ther; 2001 Sep 16; 298(3):1007-14. PubMed ID: 11504797 [Abstract] [Full Text] [Related]
14. Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB(1) receptors in the least shrew. Darmani NA. Pharmacol Biochem Behav; 2001 Sep 16; 69(1-2):239-49. PubMed ID: 11420092 [Abstract] [Full Text] [Related]
15. Regulation of delta opioid receptors by delta9-tetrahydrocannabinol in NG108-15 hybrid cells. Di Toro R, Campana G, Sciarretta V, Murari G, Spampinato S. Life Sci; 1998 Sep 16; 63(14):PL197-204. PubMed ID: 9771917 [Abstract] [Full Text] [Related]
19. Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception. Booker L, Naidu PS, Razdan RK, Mahadevan A, Lichtman AH. Drug Alcohol Depend; 2009 Nov 01; 105(1-2):42-7. PubMed ID: 19679411 [Abstract] [Full Text] [Related]
20. Pharmacological evaluation of aerosolized cannabinoids in mice. Lichtman AH, Peart J, Poklis JL, Bridgen DT, Razdan RK, Wilson DM, Poklis A, Meng Y, Byron PR, Martin BR. Eur J Pharmacol; 2000 Jul 07; 399(2-3):141-9. PubMed ID: 10884513 [Abstract] [Full Text] [Related] Page: [Next] [New Search]